Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family Registry.

Publication Type:

Journal Article


Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Volume 19, Issue 8, p.2023-34 (2010)


2010, Antineoplastic Agents, Center-Authored Paper, Clinical Research Division, Collaborative Data Services Core Facility, Colorectal Neoplasms, Dietary Supplements, Family Health, Female, folic acid, Follow-Up Studies, Health Behavior, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Prevention Center Core Facility, Prognosis, Public Health Sciences Division, Questionnaires, Registries, Research Trials Office Core Facility - Biostatistics Service, Sex Factors, Shared Resources, Specimen Processing Core Facility


Supplement use among cancer patients is high, and folic acid intake in particular may adversely affect the progression of colorectal cancer. Few studies have evaluated the use of folic acid-containing supplements (FAS) and its predictors in colorectal cancer patients.